Yahoo Web Search

Search results

    • FDA ends busy year with three drug rejections

      FDA ends busy year with three drug rejections

      BioPharma Dive via Yahoo Finance· 5 months ago

      Amgen had its bid for full approval of the cancer drug Lumakras turned back by the agency, which also issued complete response letters to Zealand Pharma...

    • Is It Too Late to Buy Viking Therapeutics Stock?

      Is It Too Late to Buy Viking Therapeutics Stock?

      Motley Fool via Yahoo Finance· 2 months ago

      Viking Therapeutics (NASDAQ: VKTX) has emerged this year as a formidable contender in the increasingly popular anti-obesity market. While it doesn't have...